Case 4-2007. Aprotinin-Induced Cardiovascular Collapse After a Negative Test Dose in a Patient Scheduled for Repeat Mitral Valve Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 4, 2007, Pages 597-601

  Beaulieu, Phillip L ^a   Gandhi, Sweeta D ^a   Iqbal, Zafar ^a   Butler, Elizabeth G ^a   Almassi, G Hossein ^a   Pagel, Paul S ^a   Levy, Jerrold H ^b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anaphylactic shock; anaphylaxis; aprotinin; cardiac surgery; epinephrine; test dose; vasodilatory shock; vasopressin

Indexed keywords

ADRENALIN; APROTININ; DEXAMETHASONE; DIPHENHYDRAMINE; ETOMIDATE; FENTANYL; FUROSEMIDE; GLYCERYL TRINITRATE; LISINOPRIL; METOPROLOL; MIDAZOLAM; PANCURONIUM; PHENYLEPHRINE; PROPOFOL; RANITIDINE; SPIRONOLACTONE; WARFARIN;

AGED; ANAPHYLAXIS; ANNULOPLASTY; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG REEXPOSURE; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HUMAN; LOADING DRUG DOSE; MALE; MITRAL VALVE; PRIORITY JOURNAL; REOPERATION; RESUSCITATION; SHOCK;

AGED; ANAPHYLAXIS; APROTININ; BLOOD LOSS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MITRAL VALVE INSUFFICIENCY; PREOPERATIVE CARE; REOPERATION; SERINE PROTEINASE INHIBITORS; SHOCK;

EID: 34547360589     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.04.008     Document Type: Article

References (23)

1. Royston D., Bidstrup B.P., Taylor K.M., et al. Effect of aprotinin on the need for blood transfusion after repeat open heart surgery. Lancet 2 (1987) 1289-1291
2. Levy J.H., Pifarre R., Schaff H.V., et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92 (1995) 2236-2244
3. Dietrich W., Spath P., Ebell A., et al. Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 113 (1997) 194-201
4. Dietrich W. Incidence of hypersensitivity reactions. Ann Thorac Surg 65 (1998) S60-S64
5. Jaquiss R.D., Ghanayem N.S., Zacharisen M.C., et al. Safety of aprotinin use and reuse in pediatric cardiothoracic surgery. Circulation 106 suppl I (2002) I-90-I-94
6. Beierlein W., Scheule A.M., Dietrich W., et al. Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions. Ann Thorac Surg 79 (2005) 741-748
7. Scheule A.M., Beierlein W., Arnold S., et al. The significance of preformed aprotonin-specific antibodies in cardiosurgical patients. Anesth Analg 90 (2000) 262-266
8. Dietrich W., Spath P., Zuhlsdorf M., et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery. Relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 95 (2001) 64-71
9. Williams S.R., Denault A.Y., Pellerin M., et al. Vasopressin for treatment of shock following aprotinin administration. Can J Anesth 51 (2004) 169-172
10. Martinelli L., Maurelli M., and Vigano M. Aprotinin in staged heart transplantation: Anaphylactic potential of repeated exposure. Ann Thorac Surg 61 (1996) 1288-1289
11. Milano C.A., Patel V.S., Smith P.K., et al. Risk of anaphylaxis from aprotinin reexposure during LVAD removal and heart transplantation. J Heart Lung Transplant 21 (2002) 1127-1130
12. Ceriana P., Maurelli M., Locatelli A., et al. Anaphylactic reaction to aprotinin. J Cardiothorac Vasc Anesth 9 (1995) 477-478
13. Diefenbach C., Abel M., Limpers B., et al. Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. Anesth Analg 80 (1995) 830-831
14. Levy J.H. Anaphylactic Reactions in Anesthesia and Intensive Care. (ed 2). (1992), Butterworth-Heinemann Publishers, Stoneham
15. Ford S.A., Kam P.C., Baldo B.A., et al. Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 15 (2001) 684-688
16. Delage C., and Irey N.S. Anaphylactic deaths: A clinicopathologic study of 43 cases. J Forensic Sci 17 (1972) 525-540
17. Moss J., Roizen M.F., Nordby E.J., et al. Decreased incidence and mortality of anaphylaxis to chymopapain. Anesth Analg 64 (1985) 1197-1201
18. Landry D.W., and Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med 345 (2001) 588-595
19. Tsuda A., Tanaka K.A., Huraux C., et al. The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth Analg 93 (2001) 1453-1459
20. Krismer A.C., Dunser M.W., Lindner K.H., et al. Vasopressin during cardiopulmonary resuscitation and different shock states: A review of the literature. Am J Cardiovasc Drugs 6 (2006) 51-68
21. Kill C., Wranze E., and Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 134 (2004) 260-261
22. Levy J.H. Anaphylactic reactions in cardiac surgical patients: Et tu, Brute?. J Cardiothorac Vasc Anesth 15 (2001) 677-679
23. Oswald A.M., Joly L.M., Gury C., et al. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 99 (2003) 762-763